• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

BioTime Inc.

Started by caliban , Mar 25 2011 01:11 AM
economics regenerative medicine stemells tissue engineering regmed

  • Please log in to reply
777 replies to this topic

#331 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 28 October 2013 - 01:08 PM

BioTime Reports Interim Results on Reneviaâ„¢ Clinical Safety Trial
EON: Enhanced Online News (press release) - 20 hours ago
EON: Enhanced Online News)--BioTime, Inc. (NYSE MKT: BTX), today announced that William Tew, Ph.D., BioTime's Chief Commercial Officer will provide an update on the development of Reneviaâ„¢ at an investor meeting in New York City.

View the full article

#332 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 28 October 2013 - 01:06 PM

BioTime Organizes New ESI BIO Division to Develop, Manufacture and Market ...
The Herald | HeraldOnline.com - 20 hours ago
BioTime, Inc. (NYSE MKT: BTX) today announced changes to the organization and management of its research products business.

View the full article

#333 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 29 October 2013 - 03:58 PM

Investors Picks: Polycom Inc (NASDAQ:PLCM), Cirrus Logic, Inc. (NASDAQ ...
Techsonian (press release) - 51 minutes ago
Cirrus Logic, Inc. (NASDAQ:CRUS) Shares have lost -4.82% to $24.51. Over the last twelve months, the stock has lost -35.86% and past five days performance showed positive change of 2.08%.

View the full article

sponsored ad

  • Advert

#334 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 29 October 2013 - 05:15 AM

INCY's Got More Proof, AKRX Hits New High, ILMN Opens Wallet, RGLS On Watch
NASDAQ - 11 hours ago
Asterias Biotherapeutics Inc., a majority-owned subsidiary of BioTime Inc. ( BTX ), plans to file a registration statement with the SEC next month for an underwritten public offering of units, with each unit consisting of one share of Series B common ...

View the full article

#335 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 28 October 2013 - 02:15 PM

Asterias Biotherapeutics, Inc. Plans to File Registration Statement for ...
Wall Street Journal - Oct 28, 2013
Asterias Biotherapeutics, Inc., a majority-owned subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that it plans to file a registration statement with the Securities and Exchange Commission in November 2013 for an underwritten public ...

View the full article

#336 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 28 October 2013 - 01:26 PM

BioTime Reports Interim Results on Reneviaâ„¢ Clinical Safety Trial
The Herald | HeraldOnline.com - Oct 28, 2013
BioTime, Inc. (NYSE MKT: BTX), today announced that William Tew, Ph.D., BioTime's Chief Commercial Officer will provide an update on the development of Reneviaâ„¢ at an investor meeting in New York City.

View the full article

#337 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 29 October 2013 - 03:59 PM

Asterias Biotherapeutics Inc proposes to file USD12m - USD15m in registration ...
MENAFN.COM - 7 hours ago
Net proceeds of the planned offering are expected to be used by the company to fund its product development programmes and for working capital.

View the full article

#338 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 28 October 2013 - 02:11 PM

Asterias Biotherapeutics, Inc. Plans to File Registration Statement for ...
Business Wire (press release) - Oct 28, 2013
BUSINESS WIRE)--Asterias Biotherapeutics, Inc., a majority-owned subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that it plans to file a registration statement with the Securities and Exchange Commission in November 2013 for an ...

View the full article

#339 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 30 October 2013 - 02:36 PM

Stock Gaps Up and Down for Oct-30 Morning
MarketsNTrade - 6 hours ago
BioTime Inc. is currently trading at $3.75 - 0.04 (1.06%). BioTime, Inc., is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic, therapeutic and research ...

View the full article

#340 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 28 October 2013 - 01:19 PM

BioTime Reports Interim Results From Renevia Safety Trial - Quick Facts
RTT News - Oct 28, 2013
BioTime Inc. (BTX: Quote) reported the completion of enrollment in a safety trial evaluating Renevia, an injectable matrix designed to facilitate the stable engraftment of transplanted cells.

View the full article

#341 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 30 October 2013 - 06:33 AM

BioTime forms ESI BIO division to develop, manufacture & market its stem cell ...
pharmabiz.com - Oct 30, 2013
Inorder to organise and manage its research products business, BioTime, Inc. has formed a new ESI BIO division which will be its primary developer, manufacturer and distributor for its growing portfolio of stem-cell-based research products.

View the full article

#342 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 29 October 2013 - 03:56 PM

Investors Picks: Polycom Inc (NASDAQ:PLCM), Cirrus Logic, Inc. (NASDAQ ...
Techsonian (press release) - Oct 29, 2013
Cirrus Logic, Inc. (NASDAQ:CRUS) Shares have lost -4.82% to $24.51. Over the last twelve months, the stock has lost -35.86% and past five days performance showed positive change of 2.08%.

View the full article

#343 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 06 November 2013 - 01:52 PM

Vista Partners Publishes November 2013 Macroeconomic & Investment Newsletter
Wall Street Journal - 1 hour ago
Tec Limited, Ohr Pharmaceutical, Inc. (NASDAQ: OHRP), BioTime, Inc., Redhawk Resources, Inc., The Alkaline Water Company Inc. Targeted Medical Pharma Inc., OpthoTech Corporation and Power Solutions International Inc. (NASDAQ: PSIX).

View the full article

#344 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 07 November 2013 - 12:33 AM

BioTime, Inc. to Provide Company Updates During Investor Day, October 28, 2013
HispanicBusiness.com - 1 hour ago
By a News Reporter-Staff News Editor at Biotech Business Week -- BioTime, Inc. (NYSE MKT: BTX) announced that it will be holding its annual Investor Day providing company updates at the Harvard Club in New York City .

View the full article

#345 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 06 November 2013 - 02:05 PM

Vista Partners Publishes November 2013 Macroeconomic & Investment Newsletter
MarketWatch - Nov 6, 2013
The Companies featured in the FREE November 2013 Newsletter are: Acorn Energy, Inc., Adriana Resources, Inc., Accelerize New Media, Inc, Mast Therapeutics, Inc. (nyse mkt:MSTX), Algae.Tec Limited, Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) , BioTime, ...

View the full article

#346 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 07 November 2013 - 09:11 PM

Geron Corporation Reports Third Quarter 2013 Financial Results
Wall Street Journal - 8 hours ago
On October 1, 2013, the transaction to divest Geron's human embryonic stem cell assets pursuant to the terms of the previously announced Asset Contribution Agreement that was entered into in January 2013 with BioTime, Inc. and BioTime's subsidiary, ...

View the full article

#347 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 07 November 2013 - 09:11 PM

Geron Corporation Reports Third Quarter 2013 Financial Results
Wall Street Journal - 19 hours ago
On October 1, 2013, the transaction to divest Geron's human embryonic stem cell assets pursuant to the terms of the previously announced Asset Contribution Agreement that was entered into in January 2013 with BioTime, Inc. and BioTime's subsidiary, ...

View the full article

#348 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 28 October 2013 - 03:45 PM

Markets Buzz: Zogenix, Inc.(NASDAQ:ZGNX), BioTime, Inc.(NYSEMKT:BTX)
SBWire (press release) - Oct 28, 2013
Orlando, FL -- (SBWIRE) -- 10/28/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages.

View the full article

#349 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 15 October 2013 - 01:16 PM


View the full article

#350 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 November 2013 - 09:56 PM

BioTime, Inc. : BioTime Announces Third Quarter 2013 Financial Results and ...
4-traders (press release) - 27 minutes ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter ended September 30, 2013 and highlighted recent corporate ...

View the full article

#351 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 November 2013 - 09:56 PM

BioTime, Inc. : BioTime Announces Third Quarter 2013 Financial Results and ...
4-traders (press release) - 3 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter ended September 30, 2013 and highlighted recent corporate ...

View the full article

#352 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 November 2013 - 09:56 PM

BioTime Announces Third Quarter 2013 Financial Results and Recent Corporate ...
Business Wire (press release) - 7 hours ago
BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter ended September 30, 2013 and highlighted recent ...

View the full article

#353 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 November 2013 - 09:56 PM

BioTime, Inc. : BioTime Announces Third Quarter 2013 Financial Results and ...
4-traders (press release) - 7 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter ended September 30, 2013 and highlighted recent corporate ...
ASTERIAS BIOTHERAPEUTICS, INC. - 10-Q - Management's Discussion and ... - HispanicBusiness.com

View the full article

#354 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 13 November 2013 - 03:22 PM

Stock Gaps Up and Down for Nov-13 Morning
MarketsNTrade - 30 minutes ago
BioTime Inc. is currently trading at $3.71 - 0.0255 (0.68%). BioTime, Inc., is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic, therapeutic and ...

View the full article

#355 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 November 2013 - 10:03 PM

BioTime Announces Third Quarter 2013 Financial Results and Recent Corporate ...
Wall Street Journal - 17 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter ended September 30, 2013 and highlighted recent corporate ...

View the full article

#356 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 06 November 2013 - 02:05 PM

Vista Partners Publishes November 2013 Macroeconomic & Investment Newsletter
MarketWatch - Nov 6, 2013
The Companies featured in the FREE November 2013 Newsletter are: Acorn Energy, Inc., Adriana Resources, Inc., Accelerize New Media, Inc, Mast Therapeutics, Inc. (nyse mkt:MSTX), Algae.Tec Limited, Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) , BioTime, ...

View the full article

#357 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 28 October 2013 - 02:15 PM

Asterias Biotherapeutics, Inc. Plans to File Registration Statement for ...
Wall Street Journal - Oct 28, 2013
Asterias Biotherapeutics, Inc., a majority-owned subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that it plans to file a registration statement with the Securities and Exchange Commission in November 2013 for an underwritten public ...

View the full article

#358 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 21 November 2013 - 05:15 AM

BioTime Insider Sells $52114 in Stock (BTX)
Zolmax - 1 hour ago
BioTime Inc. logo BioTime (NYSE:BTX) Insider William Phd Tew sold 13,860 shares of the stock in a transaction that occurred on Wednesday, November 20th.

View the full article

#359 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 25 November 2013 - 01:52 PM

BioTime, Inc. : BioTime CEO Dr. Michael West to Present at 11th Annual ...
4-traders (press release) - 1 hour ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the 11 Annual Commercial Translation of ...

View the full article

#360 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 29 October 2013 - 05:20 AM

INCY's Got More Proof, AKRX Hits New High, ILMN Opens Wallet, RGLS On Watch
RTT News - Oct 29, 2013
Asterias Biotherapeutics Inc., a majority-owned subsidiary of BioTime Inc. (BTX: Quote), plans to file a registration statement with the SEC next month for an underwritten public offering of units, with each unit consisting of one share of Series B ...

View the full article
Back to Ventures & Markets



Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

9 user(s) are reading this topic

0 members, 9 guests, 0 anonymous users

  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Ventures & Markets
  5. site rules